The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?
Due to exponential increases in incidences, low risk papillary thyroid microcarcinoma (PTMC) has become a clinical and social issue in recent years. An active surveillance (AS) management approach is an alternative to immediate surgery for patients with low risk PTMC. With decreased doubts about the...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
China Anti-Cancer Association
2022-05-01
|
| Series: | Cancer Biology & Medicine |
| Subjects: | |
| Online Access: | https://www.cancerbiomed.org/content/19/5/619 |
| _version_ | 1818545309824843776 |
|---|---|
| author | Wen Liu Xuejing Yan Ruochuan Cheng |
| author_facet | Wen Liu Xuejing Yan Ruochuan Cheng |
| author_sort | Wen Liu |
| collection | DOAJ |
| description | Due to exponential increases in incidences, low risk papillary thyroid microcarcinoma (PTMC) has become a clinical and social issue in recent years. An active surveillance (AS) management approach is an alternative to immediate surgery for patients with low risk PTMC. With decreased doubts about the safety and validity due to evidence from a large number of studies, the AS approach has become increasingly popular worldwide. However, Chinese thyroid surgeons still lag behind other countries in their knowledge of clinical practices and research related to AS. To promote the implementation of AS in China, thyroid surgeons should understand the implications, advantages, and disadvantages of management approaches for AS, and should also consider the willingness of Chinese patients, the impact on the medical billing system, and the enthusiasm of doctors. Thus, a management approach for AS based on the Chinese population should be developed to reduce the risk of disease progression and enhance patient adherence. Herein, we summarize the recent research achievements and deficiencies in AS approaches, and describe the initial experiences regarding AS in the Chinese population, in order to assist Chinese thyroid surgeons in preparing for AS management in the era of PTMC precision medicine. |
| first_indexed | 2024-12-12T07:38:37Z |
| format | Article |
| id | doaj.art-4623135ee4404a799f22431a79bef2a9 |
| institution | Directory Open Access Journal |
| issn | 2095-3941 |
| language | English |
| last_indexed | 2024-12-12T07:38:37Z |
| publishDate | 2022-05-01 |
| publisher | China Anti-Cancer Association |
| record_format | Article |
| series | Cancer Biology & Medicine |
| spelling | doaj.art-4623135ee4404a799f22431a79bef2a92022-12-22T00:32:52ZengChina Anti-Cancer AssociationCancer Biology & Medicine2095-39412022-05-0119561963410.20892/j.issn.2095-3941.2021.0058The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?Wen Liu0Xuejing Yan1Ruochuan Cheng2Department of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, ChinaDepartment of Management of Chronic Non-communicable Diseases, Yunnan Center for Disease Control and Prevention, Kunming 650034, ChinaDepartment of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, ChinaDue to exponential increases in incidences, low risk papillary thyroid microcarcinoma (PTMC) has become a clinical and social issue in recent years. An active surveillance (AS) management approach is an alternative to immediate surgery for patients with low risk PTMC. With decreased doubts about the safety and validity due to evidence from a large number of studies, the AS approach has become increasingly popular worldwide. However, Chinese thyroid surgeons still lag behind other countries in their knowledge of clinical practices and research related to AS. To promote the implementation of AS in China, thyroid surgeons should understand the implications, advantages, and disadvantages of management approaches for AS, and should also consider the willingness of Chinese patients, the impact on the medical billing system, and the enthusiasm of doctors. Thus, a management approach for AS based on the Chinese population should be developed to reduce the risk of disease progression and enhance patient adherence. Herein, we summarize the recent research achievements and deficiencies in AS approaches, and describe the initial experiences regarding AS in the Chinese population, in order to assist Chinese thyroid surgeons in preparing for AS management in the era of PTMC precision medicine.https://www.cancerbiomed.org/content/19/5/619papillary thyroid carcinomamicrocarcinomaactive surveillanceobservation |
| spellingShingle | Wen Liu Xuejing Yan Ruochuan Cheng The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready? Cancer Biology & Medicine papillary thyroid carcinoma microcarcinoma active surveillance observation |
| title | The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready? |
| title_full | The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready? |
| title_fullStr | The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready? |
| title_full_unstemmed | The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready? |
| title_short | The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready? |
| title_sort | active surveillance management approach for patients with low risk papillary thyroid microcarcinomas is china ready |
| topic | papillary thyroid carcinoma microcarcinoma active surveillance observation |
| url | https://www.cancerbiomed.org/content/19/5/619 |
| work_keys_str_mv | AT wenliu theactivesurveillancemanagementapproachforpatientswithlowriskpapillarythyroidmicrocarcinomasischinaready AT xuejingyan theactivesurveillancemanagementapproachforpatientswithlowriskpapillarythyroidmicrocarcinomasischinaready AT ruochuancheng theactivesurveillancemanagementapproachforpatientswithlowriskpapillarythyroidmicrocarcinomasischinaready AT wenliu activesurveillancemanagementapproachforpatientswithlowriskpapillarythyroidmicrocarcinomasischinaready AT xuejingyan activesurveillancemanagementapproachforpatientswithlowriskpapillarythyroidmicrocarcinomasischinaready AT ruochuancheng activesurveillancemanagementapproachforpatientswithlowriskpapillarythyroidmicrocarcinomasischinaready |